Tenderwize
Back to tender search

Open-house rebate agreements for Etanercept

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 05, 2026 · 19 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Etanercept, ATC L04AB01

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

52 / 100

Complexity

58 / 100

Risk factors

For paper submissions, the notice requires duplicate originals and a prior fax/scan/email/portal transmission only pres...

Participation is limited to pharmaceutical companies and requires a signed reliability self-declaration.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2026
  • Non-exclusive rebate agreements for the medicinal product Etanercept, ATC L04AB01.
  • Open-house model with identical, pre-set contract terms for all eligible pharmaceutical companies.
Show full summary

Open-house supply arrangement for pharmaceutical products: non-exclusive rebate agreements for Etanercept (ATC L04AB01) offered by AOK Bayern to all interested pharmaceutical companies that meet the stated suitability requirement. This is explicitly described as a non-competitive open-house model with no selection decision and no negotiated terms. Contracting is possible throughout the term, with the latest contract conclusion date on 2026-09-05. Submission can be made electronically with a qualified electronic signature or in paper form; documents not in German must be submitted with a German translation.

Risks

For paper submissions, the notice requires duplicate originals and a prior fax/scan/email/portal transmission only pres...

Participation is limited to pharmaceutical companies and requires a signed reliability self-declaration.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submission of a completed and signed self-declaration on reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submission of the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreements for Etanercept

Open-house supply lot for non-exclusive rebate agreements concerning the active substance Etanercept (ATC L04AB01). The notice states that all interested pharmaceutical companies meeting the suitability requirement may join on identical, non-individually negotiable terms. Place of performance is Germany, specifically DE212 (Bavaria/Munich region in the notice metadata).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2024 - Oct 2026

Category

Pharmaceutical products

Deadline

Deadline Sep 05, 2026

Procurement Details

Publication date
16 Sep 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
557440-2024

Documents (2)

Similar tenders